NEUPERT PETER M
SEC CIK 1237566 · EDGAR
BoughtSold
Most active insiders at ADPT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ROBINS CHAD M | CEO, COB, Dir | — | $39.80M |
| 2 | ROBINS HARLAN S | CSO | — | $29.65M |
| 3 | BENZENO SHARON | Chief Commercial Ofc Imm Med | — | $14.69M |
| 4 | RUBINSTEIN JULIE | Pres, COO | — | $13.37M |
| 5 | LO FRANCIS | CHRO | — | $13.21M |
| 6 | PISKEL KYLE | CFO | — | $3.58M |
| 7 | NEUPERT PETER M | Dir | — | $3.14M |
| 8 | GRIFFIN MICHELLE RENEE | Dir | — | $2.00M |
| 9 | BOBULSKY SUSAN | Chief Commercial Off, MRD | — | $1.20M |
| 10 | HERSHBERG ROBERT | Dir | — | $1.12M |
Transactions 22
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-19 20:07 | 2026-08-17 | ADPT | Adaptive Biotechnologies Corp | NEUPERT PETER M | Dir | M - OptEx | $6.32 | +15.0K | 255.3K | +6% | +$94.8K |
| DM | 2026-08-19 20:07 | 2026-08-17 | ADPT | Adaptive Biotechnologies Corp | NEUPERT PETER M | Dir | S - Sale+OE | $25.15 | -124.7K | 130.6K | -49% | -$3.14M |
| D | 2026-05-18 16:34 | 2026-05-14 | FTRE | Fortrea Holdings Inc. | NEUPERT PETER M | Dir | M - OptEx | $0.00 | +148.5K | 246.7K | +151% | $0 |
| 2026-03-06 | 2026-03-04 | ADPT | Adaptive Biotechnologies Corp | NEUPERT PETER M | Dir | A - Grant | $0.00 | +15.6K | 240.3K | +7% | $0 | |
| D | 2026-02-13 | 2026-02-11 | LH | Labcorp | NEUPERT PETER M | Dir | M - OptEx | — | +897 | 13.8K | +7% | — |
| M | 2025-08-11 | 2025-08-08+ | FTRE | Fortrea Holdings Inc. | NEUPERT PETER M | Dir | P - Purchase | $6.51 | +62.5K | 98.1K | +175% | +$407.1K |
| D | 2025-05-16 | 2025-05-14 | FTRE | Fortrea Holdings Inc. | NEUPERT PETER M | CEO, Dir | M - OptEx | $0.00 | +7,282 | 35.6K | +26% | $0 |
| D | 2025-03-12 | 2025-03-10 | ADPT | Adaptive Biotechnologies Corp | NEUPERT PETER M | Dir | S - Sale+OE | $7.05 | -10.0K | 224.7K | -4% | -$70.5K |
| D | 2025-03-12 | 2025-03-10 | ADPT | Adaptive Biotechnologies Corp | NEUPERT PETER M | Dir | M - OptEx | $4.07 | +50.0K | 234.7K | +27% | +$203.5K |
| D | 2025-03-06 | 2025-03-04 | ADPT | Adaptive Biotechnologies Corp | NEUPERT PETER M | Dir | A - Grant | $0.00 | +15.4K | 184.7K | +9% | $0 |
| D | 2025-02-10 | 2025-02-06 | LH | Labcorp | NEUPERT PETER M | Dir | M - OptEx | — | +944 | 12.9K | +8% | — |
| D | 2024-07-19 | 2024-07-18 | FTRE | Fortrea Holdings Inc. | NEUPERT PETER M | Dir | M - OptEx | $0.00 | +6,354 | 28.4K | +29% | $0 |
| D | 2024-03-13 | 2024-03-12 | ADPT | Adaptive Biotechnologies Corp | NEUPERT PETER M | Dir | M - OptEx | $0.84 | +15.0K | 169.3K | +10% | +$12.6K |
| D | 2024-03-06 | 2024-03-04 | ADPT | Adaptive Biotechnologies Corp | NEUPERT PETER M | Dir | A - Grant | $0.00 | +31.3K | 154.3K | +25% | $0 |
| D | 2024-02-08 | 2024-02-07 | LH | Labcorp | NEUPERT PETER M | Dir | M - OptEx | — | +947 | 11.9K | +9% | — |
| D | 2023-12-15 | 2023-12-13 | ADPT | Adaptive Biotechnologies Corp | NEUPERT PETER M | Dir | M - OptEx | $0.84 | +100.0K | 123.0K | +435% | +$84.0K |
| 2023-08-23 | 2023-08-23 | FTRE | Fortrea Holdings Inc. | NEUPERT PETER M | Dir | P - Purchase | $25.30 | +11.0K | 22.0K | +100% | +$278.3K | |
| D | 2023-03-08 | 2023-03-06 | ADPT | Adaptive Biotechnologies Corp | NEUPERT PETER M | Dir | A - Grant | $0.00 | +14.8K | 23.0K | +180% | $0 |
| D | 2023-02-14 | 2023-02-11 | LH | Labcorp | NEUPERT PETER M | Dir | M - OptEx | — | +742 | 11.0K | +7% | — |
| M | 2022-02-18 | 2022-02-16 | LH | Labcorp | NEUPERT PETER M | Dir | P - Purchase | $263.66 | +3,500 | 10.3K | +52% | +$922.8K |
| D | 2022-02-04 | 2022-02-02 | LH | Labcorp | NEUPERT PETER M | Dir | M - OptEx | — | +771 | 6,754 | +13% | — |
| D | 2022-01-28 | 2022-01-26 | ADPT | Adaptive Biotechnologies Corp | NEUPERT PETER M | Dir | A - Grant | $0.00 | +6,689 | 8,193 | +445% | $0 |
Purchase Sale Sale after option exercise All abbreviations